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The tumor promoter, phorbol 12-myristate 13-acetate (PMA), enhances tumor yield through an 
epigenetic mechanism.  PMA, like another promoter, phosphatase inhibitor okadaic acid, works by 
maintaining proteins in a phosphorylated state.  In order to identify chemicals with promoter and 
antipromoter effects, this laboratory has developed a standard curve of morphogenetic changes using 
data from precancerous cell lines that eventually became neoplastic.  Using the curve as a basis of 
comparison, we defined the “signature” phenotype as that adopted when a cell line became 
neoplastic.  The results of solving for signature type disclosed that the microtubule-depolymerizing 
compound, colchicine, had a promoter-like effect [2].  The opposite effect was found if cells were 
exposed to paclitaxel (Taxol®) and colchicine [3].  Such findings gave clinicians a rationale to test 
microtubule inhibitor combinations [4].  Therapy is only effective when agents are administered 
nearly simultaneously.  In the current work, we study the effect of inhibitor combinations on cell 
features defined by computer-assisted microscopy and classification methods based on latent factors.   
 
When administered to cells, paclitaxel or cephalomannine alone enhanced factor #7, a descriptor of 
protrusions dependent upon p21-associated kinase [5].  The agents left factor #4, representing 
filopodia or microspikes, unaffected.  Paclitaxel administered along with various microtubule-
depolymerizing compounds elevated factor #7.  1:1 combinations of paclitaxel with colchicine, 
nocoazole, or vinblastine, all had the same effect.  A 3:1 molar ratio of paclitaxel to podophyllotoxin 
or vinblastine was similar.  Thus, protrusions were commonly enhanced by taxanes alone or in 
combination with depolymerizing agent.  The prevalence of filopodia, determined by comparing 
factor #4 values with control, was only affected by an equimolar combination of paclitaxel and 
colchicine or 3:1 molar ratio of paclitaxel to podophyllotoxin.  This endpoint was unaffected by 
taxane exposure but did respond to a high concentration of the paclitaxel analog, 7-deoxytaxol.  
Morphological correlates of the two types of cell features were sought by immunofluorescence 
localization of  microtubules in cells fixed with -20˚ methanol.  Control cells exhibited numerous 
microtubules arranged parallel to the cell edge (Fig. 1a).  Only where cells made contact did 
microtubules typically appear to be perpendicular to the cell edge.  In contrast, after 2 h exposure to 
the combination of paclitaxel with colchicine, microtubules were rearranged so that a part of the 
array extended straight out from the peripheral cytoplasm (Fig. 1b).  This effect was observed after 
exposure to paclitaxel with podophyllotoxin and vinblastine (Fig. 2) as well.  From these studies, it 
can be concluded that both the features represented by #4 and #7 can be influenced by taxanes and 
for #4, particularly by the combination of paclitaxel with microtubule-depolymerizing agents. 
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 Fig. 1. Comparison of IAR20 PC1 cells showing the arrangement of microtubules.  Cells were 
stained with mouse antibody against beta-tubulin, followed by FITC-labelled anti-mouse antibody.  
A) Control with vehicle only.  At the cell boundary (arrow), microtubules are arranged parallel to the 
edge.  B) Cells treated with combination of microtubule inhibitors 2 µM paclitaxel and 2 µM 
colchicine.  Bar = 10 µm. 
 
 
Fig. 2. Comparison of IAR20 PC1 cells treated with a combination of microtubule inhibitors. (Left) 
Cells treated with 6 µM paclitaxel plus 2 µM vinblastine. (Right) Cells treated with 6 µM paclitaxel 
plus 2 µM podophyllotoxin.  Cell edges show microtubules extending perpendicularly onto the 
substrate. 
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